Eagle Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
RG
ACA
PAI
Eagle Asset Management's FOLD Position: Q2 2021 in Review
Eagle Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 1,616,670 shares — an estimated $16.3M sold.
Eagle Asset Management first reported a position in FOLD in Q3 2017 and held it in 15 quarters. The position peaked at $57.6M in Q4 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.
- Eagle Asset Management reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
- Eagle Asset Management sold 1,616,670 Amicus Therapeutics shares in Q2 2021, an estimated $16.3M.
- Eagle Asset Management first reported a position in Amicus Therapeutics in Q3 2017 and held it in 15 quarters.
- Eagle Asset Management's Amicus Therapeutics position peaked at $57.6M in Q4 2020.
- 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.
Based on Eagle Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.